Single-dose treatment of gonorrhoea with cotrimoxazole. A report on 1,223 cases.
AUTOR(ES)
Rahim, G
RESUMO
1,223 ambulant patients with gonorrhoea were each treated with a single dose of eight tablets of cotrimoxazole. 1,069 patients were followed up (794 males and 275 females). Of these, only 46 (4%) failed to respond. Cotrimoxazole in the dosage used was well tolerated by all the patients, with very few side-effects. There was clear evidence that cotrimoxazole did not mask concomitant syphilitic infections; neither did it produce a gonococcal carrier state. The incidence of post-gonococcal non-specific urethritis was 6 per cent. At present cotrimoxazole seems to be the most useful alternative to penicillin in the treatment of gonorrhoea.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1045148Documentos Relacionados
- Letter: Single-dose oral treatment of gonorrhoea.
- Single-dose treatment of uncomplicated gonorrhoea in males with minocycline.
- Doxycycline in the single-dose treatment of gonorrhoea. Effect on Treponema pallidum.
- Minocycline hydrochloride (Minocin) as a single-dose oral treatment of uncomplicated gonorrhoea in men.
- Single-dose treatment of gonorrhoea with penicillin or thiamphenicol and its effect on T. pallidum in experimental syphilis.